These markers include tumor burden, liver function, and physical status, which are further refined by Alpha-Fetoprotein (AFP), Albumin–Bilirubin Index (ALBI) score, Child–Pugh, and Model for End-Stage Liver Disease (MELD) [3]. The gene discussed is AFP; the disease is neoplasm.